Sirtsei Pharmaceuticals, Inc.
Clinical trials sponsored by Sirtsei Pharmaceuticals, Inc., explained in plain language.
-
Could a new pill rewire depressed brains? early trial begins
Symptom relief Recruiting nowThis early-stage study tests an experimental drug called SP-624 in 36 adults—some healthy and some with major depression. Participants take the drug or a placebo daily for two weeks. Researchers use EEG brain scans and AI to see if SP-624 changes brain activity and improves memor…
Phase: PHASE1 • Sponsor: Sirtsei Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:07 UTC
-
New depression drug shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests whether a new medicine called SP-624 can safely reduce depression symptoms in adults with moderate to severe major depressive disorder. About 456 people will receive either SP-624 or a placebo (a dummy pill) for several weeks, and researchers will track changes i…
Phase: PHASE2 • Sponsor: Sirtsei Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 20:01 UTC